Indeed, the expression of NLRP3, ASC, caspase-1, and IL-1β were reported to be significantly increased in active demyelinating lesion of MS, while their expression levels were greatly reduced in chronic inactive lesions of MS [61]. The gene discussed is NLRP3; the disease is myeloid sarcoma.